发明名称 LRRK2 INHIBITORS
摘要 Provided herein are compounds that inhibit or partially inhibit the activity of leucine rich repeat kinases. Also provided herein are methods of treatment of CNS disorders comprising administration of inhibitors of leucine rich repeat kinases.
申请公布号 US2014205537(A1) 申请公布日期 2014.07.24
申请号 US201214129099 申请日期 2012.06.22
申请人 Bounaud Pierre-Yves;Nienaber Vicki;Steensma Ruo W.;Lowe, III John A. 发明人 Bounaud Pierre-Yves;Nienaber Vicki;Steensma Ruo W.;Lowe, III John A.
分类号 C07D403/06;C07D417/06;C07D401/14;C07D413/06;C07D405/14;C07D471/04;C07D401/06 主分类号 C07D403/06
代理机构 代理人
主权项 1. A compound, or salt thereof, of formula (I-Z-2): wherein R1 is pyrazole, imidazol-5-yl, triazolyl, triazolonyl, indoly-2-yl, indol-4-yl, indol-5-yl, indole-6-yl, indol-7-yl, benzimidazolyl, azabenzimidazolyl, azaindolyl, benzothiazolyl or benzoxazolyl, where R1 is optionally substituted with one, two, three, four, or five R6; each R6 is independently hydroxy, halo, optionally substituted alkyl, optionally substituted alkoxy, optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted heteroalkyl optionally substituted heteroalicyclyl, optionally substituted alkylcycloalkyl, optionally substituted alkylheteroalicyclyl, C(O)R, C(O)OR, NR′R″, NR′C(O)R″, NRC(O)NR′R″, NR′S(O)2R″, C(O)NR′R″, S(O)2R, or S(O)2NR′R″;R1a is hydrogen, optionally substituted alkyl, optionally substituted heteroalkyl, optionally substituted cycloalkyl or optionally substituted heteroalicyclyl;each of R2 and R4 is independently hydrogen, hydroxy, halo, haloalkyl, haloalkoxy, alkyl, cycloalkyl, alkoxy, aryl, heteroaryl, or heteroalkyl, C(O)R, C(O)OR, NR′R″, NR′C(O)R″, NRC(O)NR′R″, NR′S(O)2R″, C(O)NR′R″, S(O)2R, or S(O)2NR′R″;R3 is hydroxy, halo, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted alkoxy, optionally substituted cycloalkyloxy, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted heteroalkyl, C(O)R, C(O)OR, NR′R″, NR′C(O)R″, NRC(O)NR′R″, NR′S(O)2R″, C(O)NR′R″, S(O)2R, or S(O)2NR′R″;R5 is hydrogen, halo, haloalkyl or alkyl; and each of R, R′ and R″ are independently hydrogen, alkyl, haloalkyl, cycloalkyl, aryl, heteroaryl, or heteroalkyl; orR′ and R″ taken together with the nitrogen to which they are attached form a ring structure that optionally includes an additional heteroatom selected from N or O and is optionally substituted.
地址 San Diego CA US